Similarly, multiple in vitro studies have demonstrated that BAFF stimulation reduces the chemosensitivity of cancer cells, including multiple myeloma, chronic lymphocytic leukemia, and mantle cell lymphoma cells [26,27,28,29]. This evidence concerns the gene TNFSF13B and mantle cell lymphoma.